JLE

Epileptic Disorders

MENU

Neonatal hyperekplexia with homozygous p.R392H mutation in GLRA1 Volume 16, numéro 3, September 2014

  • [Carta et al., 2012] Carta E., Chung S.K., James V.M. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem. 2012;287:28975-28985.
  • [Chen et al., 2007] Chen C.H., Lee H.F., Chi C.S. Hyperekplexia (startle disease) mimicking neonatal seizures: report of one case. Acta Paediatr Taiwan. 2007;48:20-22.
  • [Chung et al., 2010] Chung S.K., Vanbellinghen J.F., Mullins J.G. Pathophysiological mechanisms of dominant and recessive mutations in hyperekplexia. J Neurosci. 2010;30:9612-9620. GLRA1
  • [Chung et al., 2013] Chung S.K., Bode A., Coussin T.D. GLRB is the third major gene-of-effect in Hyperekplexia. Hum Mol Genet. 2013;22:927-940.
  • [Harvey et al., 2008] Harvey R.J., Topf M., Harvey K., Rees M.I. The genetics of hyperekplexia: more than startle!. Trends Genet. 2008;24:439-447.
  • [McMaster et al., 1999] McMaster P., Cadzow S., Vince J. Hyperekplexia: a rare differential of neonatal fits described in a developing country. Ann Trop Paediatr. 1999;19:345-348.
  • [Rea et al., 2002] Rea R., Tijssen M.A., Troupeau C., Frantz R.R., Kullmann D.M. Functional characterization of compound heterozygosity for GlyRalpha1 mutations in the startle disease hyperekplexia. Eur J Neurosci. 2002;16:186-196.
  • [Rees et al., 1994] Rees M.I., Andrew M., Jawad S., Owen M.J. Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the 1-subunit of the inhibitory glycine receptor. Hum Mol Genet. 1994;3:2175-2179.
  • [Rees et al., 2006] Rees M.I., Harvey K., Pearce B.R. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet. 2006;38:801-806.
  • [Shahar and Raviv, 2004] Shahar E., Raviv R. Sporadic major hyperekplexia in neonates and infants: clinical manifestations and outcome. Pediatr Neurol. 2004;31:30-34.
  • [Shahar et al., 1991] Shahar E., Brand N., Uziel Y., Barak Y. Nose tapping test inducing a generalized flexor spasm: a hallmark of hyperexplexia. Acta Paediatr Scand. 1991;80:1073-1077.
  • [Shiang et al., 1993] Shiang R., Ryan S.G., Zhu Y.Z., Hahn A.F., O’Connell P., Wasmuth J.J. Mutations in the alpha1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet. 1993;5:351-358.
  • [Thomas et al., 2013] Thomas R.H., Chung S.K., Wood S.E. Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay. Brain. 2013;136:3085-3095.
  • [Vergouwe et al., 1999] Vergouwe M.N., Tijssen M.A., Peters A.C., Wielaard R., frantz R.R. Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations. Ann Neurol. 1999;46:634-638.
  • [Vigevano et al., 1989] Vigevano F., Di Capua M., Dalla-Bernardina B. Startle disease: an avoidable cause of sudden infant death. Lancet. 1989;1:216.
  • [Villmann et al., 2009] Villmann C., Oertel J., Melzer N., Becker C.M. Recessive hyperekplexia mutations of the glycine receptor alpha1 subunit affect cell surface integration and stability. J Neurochem. 2009;111:837-847.